These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8259080)

  • 1. Late luteal phase dysphoric disorder: a scientific puzzle.
    Severino SK
    Med Hypotheses; 1993 Sep; 41(3):229-34. PubMed ID: 8259080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
    FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ
    Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep EEG studies during early and late partial sleep deprivation in premenstrual dysphoric disorder and normal control subjects.
    Parry BL; Mostofi N; LeVeau B; Nahum HC; Golshan S; Laughlin GA; Gillin JC
    Psychiatry Res; 1999 Feb; 85(2):127-43. PubMed ID: 10220004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study.
    Yatham LN
    Can J Psychiatry; 1993 Dec; 38(10):662-4. PubMed ID: 8313305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to flumazenil in women with premenstrual dysphoric disorder.
    Le Mellédo JM; Van Driel M; Coupland NJ; Lott P; Jhangri GS
    Am J Psychiatry; 2000 May; 157(5):821-3. PubMed ID: 10784479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late luteal phase dysphoric disorder.
    Hurt SW; Schnurr PP
    Psychosom Med; 1992; 54(6):723-8. PubMed ID: 1454966
    [No Abstract]   [Full Text] [Related]  

  • 7. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
    Stewart DE; Fairman M; Barbadoro S; Zownir P; Steiner M
    Biol Psychiatry; 1994 Aug; 36(3):201-2. PubMed ID: 7948458
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered serotonergic activity in women with dysphoric premenstrual syndromes.
    Halbreich U; Tworek H
    Int J Psychiatry Med; 1993; 23(1):1-27. PubMed ID: 8514462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium lactate infusion in late luteal phase dysphoric disorder.
    Sandberg D; Endicott J; Harrison W; Nee J; Gorman J
    Psychiatry Res; 1993 Jan; 46(1):79-88. PubMed ID: 8464958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder.
    Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
    Sleep Med; 2012 Sep; 13(8):1071-8. PubMed ID: 22749440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects.
    Parry BL; LeVeau B; Mostofi N; Naham HC; Loving R; Clopton P; Gillin JC
    J Biol Rhythms; 1997 Feb; 12(1):34-46. PubMed ID: 9104689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder.
    Halbreich U; Petty F; Yonkers K; Kramer GL; Rush AJ; Bibi KW
    Am J Psychiatry; 1996 May; 153(5):718-20. PubMed ID: 8615423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects.
    Bannbers E; Kask K; Wikström J; Risbrough V; Poromaa IS
    Psychoneuroendocrinology; 2011 Sep; 36(8):1184-92. PubMed ID: 21435793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High nocturnal body temperature in premenstrual syndrome and late luteal phase dysphoric disorder.
    Severino SK; Wagner DR; Moline ML; Hurt SW; Pollak CP; Zendell S
    Am J Psychiatry; 1991 Oct; 148(10):1329-35. PubMed ID: 1897612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic function and late luteal phase dysphoric disorder.
    Veeninga AT; Westenberg HG
    Psychopharmacology (Berl); 1992; 108(1-2):153-8. PubMed ID: 1410137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-endorphin decline in late luteal phase dysphoric disorder.
    Giannini AJ; Martin DM; Turner CE
    Int J Psychiatry Med; 1990; 20(3):279-84. PubMed ID: 2265889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late luteal phase dysphoric disorder and DSM-III-R.
    Spitzer RL; Severino SK; Williams JB; Parry BL
    Am J Psychiatry; 1989 Jul; 146(7):892-7. PubMed ID: 2742015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.